As one who has worked on the identification and quantification of apoptotic events in tissue sections (most notably of the intestine) since about 1974, I had become accustomed to a marked reluctance, in some cases overt hostility, to accepting the concept of apoptotic death. I am therefore extremely gratified to observe that the idea of apoptotis occurring in normal, tumour and cytotoxically exposed tissue is not only widely accepted but has burgeoned into a rapidly expanding field of study.
I have listened to many scientific presentations and read a large number of poster presentations and papers, all of which present measurements of apoptotic yield in a variety of experimental circumstances, usually using sections of tissue, cell suspensions from tissues or cells in culture, and presenting the data in the form of an apoptotic index (AI) (i.e. a measure of the number of apoptotic events or cell deaths expressed as a ratio or percentage of all cells present or all cells counted). I feel that several words of caution are perhaps appropriate at this time.
Those individuals who count apoptotic events and wish to express relative changes in the numbers of these events by way of an apoptotic index are in danger of finding themselves in a similar situation to that which cell kineticists went through in the 1950s and 1960s when presenting labelling indices that were a measure of a proportion of S-phase cells in tissue sections or cell suspensions. The problems faced were as follows: 1. The labelling index (LI) is directly dependent on the number of S-phase cells and the duration of S-phase. The latter was either largely unknown or assumed to be identical in all situations studied. In retrospect, S-phase durations did not vary enormously in the majority of cases. Little is known about the duration of apoptosis in most situations (see below). 2. The LI in many normal tissues also exhibits daily fluctuations (circadian rhythms), which make isolated single measurements difficult to assess. The AI shows similar rhythms at least in one tissue, the intestine (Potten, 1977; Potten et al., 1976 What I would like to attempt here is to consider these problems and others in relation to apoptotic index measurements. Rather than attempt to cover all tissues and cell culture systems I should like to consider just one case, the small intestine, which has been fairly extensively studied over the years. For extensive reviews of the cellular and kinetic organisation see Wright and Alison (1984) and Potten (1995) . This could be used as a model for other situations. Inevitably, therefore, I will draw heavily on our own experiences in studying this tissue. I do not wish to create a negative atmosphere concerning apoptotic index but merely to draw attention to potential problems and pitfalls.
Duration of apoptosis and detection efficiency of small fragments The duration of the apoptotic process is largely unknown. The microscopically visible part of the process will depend upon the characteristics of the tissue or cell system being studied, the degree of fragmentation that occurs during the apoptotic process, the mechanisms of removal of the apoptotic fragments and the sensitivity of the detection procedures. Some of these aspects have been studied in the gastrointestinal tract, where we have demonstrated that irradiation-induced apoptosis results in the production of, on average, three apoptotic fragments; but there is a wide range of values (Figure 1 ). These fragments are removed in the intestinal epithelium by phagocytic digestion within healthy neighbouring epithelial cells that are themselves migrating from the crypt to the villus in the small intestine. In other situations the removal is achieved by macrophages. In either case the fragments become smaller with the passage of time and in the intestine also move, or are displaced, along the crypt-villus axis Potten, 1983, 1987a, b; The determination of the half-life of these fragments depends on the efficiency with which small fragments can be detected. Some such fragments may not in fact contain condensed chromatin, being merely cytoplasmic remnants of the dying cell, and are very difficult to detect. Studies involving the temporal events leading to the production and removal of apoptosis following various cytotoxic agents suggest that the half-life may even vary depending on the cytotoxic agent being considered (Potten, 1977; Potten et al., 1977; Potten, 1983, 1987a) . Following an S-phasespecific agent such as hydroxyurea the half-life appears to be about 3.5 h, while removal of apoptosis generated by radiation, which is less cell cycle specific, would appear to be about 12 h (Figure 2 ) (see also Merritt et al., 1990) . These must be regarded as very crude estimates of the half-life of apoptotic bodies and probably represent upper limits as the yields observed at these later times will be influenced by cells entering apoptosis at the same times. Studies in the developing kidney of the rat in which the fall in apoptosis was measured, following injection of epidermal growth factor (which was assumed to block developmental apoptosis in this system) suggested that the clearance time was very short at 1-2 h (Coles et al., 1993). However, it is possible that during development many cellular processes proceed at a faster rate than in adults.
Although these half-lives differ by a factor of more than 2, they are of the same order of magnitude as the duration of Sphase. Hence, the apoptotic index may loosely be compared with proliferative parameters such as the labelling index and c ;E0.01 Figure 2 The rate of removal of apoptotic fragments in sections of crypts after various treatments. The half-life can be estimated from such decay curves. Many unpublished data have been pooled. Each point is the mean of four mice (50 crypts per mouse). No obvious differences could be detected when the data for different doses were analysed separately. This is also indicated by the amount of scatter of the individual datum points. may under some circumstances be used like a labelling index. In fact, there may be value in considering the ratio of LI to Al, which effectively removes the uncertainties relating to the denominator (Allan et al., 1992). However, it should be realised that a factor of 2 difference in the duration of Hall et al., 1994) , but this tends to be somewhat subjective. Ideally, the fragment distribution should be determined (as above) using thick sections or, better still, whole mounts of pieces of tissue under circumstances in which the cell deaths are more discrete, separated entities and, hence, clustered fragments can be more reliably assessed (Potten, 1977; Potten, 1983, 1987a by Tannock (1976) and Potten et al. (1988) for correcting mitotic counts. We have addressed these geometric questions in sections of the small intestine by comparing counts made from sections with counts in whole mounts of crypts in which all the nuclei and all the apoptotic events with their fragments are present (Potten et al., 1988; Merritt et al., 1996) . In the crypt, the situation is further complicated in sections because apoptotic fragments tend to be centripetally displaced and because counting must be performed on longitudinal sections that pass through the central axis of the crypt. These facts increase the chances of detecting fragments. Using whole mounts and sections prepared from the same intestine of irradiated animals, we have shown that sections detect about 20-30% of all apoptotic events and 50% of all fragments that occur in a whole crypt. These percentages are likely to be different in different tissues and situations.
Composition of the denominator
Very similar uncertainties exist in relation to the compartmentalisation of the denominator of the apoptotic index or labelling index. This complication is significantly reduced in situations analogous to our studies in the intestinal epithelium, where the cell types at each cell position in the crypt, or in the crypt as a whole, are fairly well understood and defined. However, this is not the case in many other tissues and is certainly not the case in random sections cut through tumours. Here, there is the added major complication that tumours often contain large or even microscopic foci of necrosis and, at the level of the light microscope, it could be very difficult to distinguish necrotic and apoptotic cells. There are also major differences in the growth rates of cells at different locations within any given tumour, and there may well be similar differences in the rate of cell death.
Flow cytometric approaches
Another consideration is the fact that techniques are increasingly being adopted for measuring the apoptotic index using flow cytometry. Here, as with all flow cytometric analysis, the precise characteristics of the cells that constitute the denominator are uncertain and are probably variable. This partially explains the frequent discrepancy between S-phase fractions flow cytometrically determined and tritriated thymidine or labelling indices determined using bromodeoxyuridine from histology preparations. Such discrepancies between flow cytometry and histomeric measurements are also to be expected when apoptosis is the end point, but will be exacerbated by the fact that a wide variety of different technical approaches have been adopted for identifying apoptotic cells using the flow cytometer (hypodiploid fractions, specific stains, end labelling techniques, etc). Thus, comparisons between apoptotic indices determined flow cytometrically from one tissue and one laboratory and those determined in another laboratory should be viewed with caution. Even greater caution should be observed when comparing flow cytometric measurements with measurements based on morphological criteria in tissue sections.
In vitro vs in vivo systems
A particular uncertainty may exist here relating to in vitro systems as flow cytometric approaches can often be applied to such systems. A question that has not been, to my knowledge, adequately addressed is whether the apoptotic response of cells in culture bears any relationship to the behaviour of the same cell types in vivo. Cell culture systems are clearly of great value in characterising the process of cell death and identifying the genes, cellular checkpoints and mechanisms involved. Certainly, cell cycle times in vitro often bear little relationship to those of the same cell types in vivo. However, these questions and those relating to how intercellular communication and interactions with the extracellular matrix influence apoptosis and apoptosisrelated gene expression in vivo are currently being addressed in part by the use of appropriate in vitro systems. Some attempts to address these questions have been made using transfected rat fibroblasts grown in vitro and subcutaneously in immune-deficient mice. (Arends et al., 1994) . Here, it has been shown that cells with a high apoptotic rate in vitro produced slow-growing tumours with a high level of apoptosis, and the converse was also true. These authors also used the ratio of apoptosis to mitosis to reduce the complications attributable to the poorly defined composition of the denominator, an approach also suggested by Allan et al. (1992) .
One point to bear in mind here is that, in most cases, in order to grow cells in culture, survival signals and conditions have inevitably been maximised. This may be to the detriment of our ability to induce apoptosis. Thus, although a given agent or treatment may be capable of overcoming the in vivo counter apoptosis or survival signals and triggering apoptosis, the same treatment in vitro may not be capable of overcoming the stronger survival signals and survival environment. Thus, it may be necessary to remove growth/ survival factors in vitro before apoptosis can be triggered. These concepts inevitably raise the question of whether survival or death signals are the basic instructions for cells. Arguments can be presented to suggest that death (apoptosis) is the fall-back (default) status for all cells (Raff, 1992 al., 1996) . The variability of these numbers depends on the techniques and samples studied. In my view, it would at present be dangerous to attempt to relate apoptotic indices, determined using such end labelling techniques, with data obtained when morphological criteria are considered. There is the additional question ofwhether such end labelling techniques can distinguish between breaks induced by a particular treatment regimen (i.e radiation exposure) and those involved in the necrotic degradation of cells (Ansari et al., 1993) . There is also some indication that the DNA becomes progressively more degraded with delay in fixation . Thus, in tumour samples subjected to end labelling approaches and analysed in the flow cytometer, it might be expected that no distinction could be made between cells from a necrotic centre and apoptotic cells in healthy growing tumour tissue. It is worth noting that in some tissues, for example the testis during spermatogenesis, both necrosis and apoptosis occur as part of the natural events and both are enhanced following exposure to agents such as radiation (Allan et al., 1987) . The testis is also a classic example of the strong hierarchical dependence of both of these processes in terms of the cell lineages that characterise this tissue (see below). ISEL is but one example of the expanding range ofdetection approaches being used. These include various modifications of end labelling procedures which involve different labelled precursors and different enzymes, e.g. deoxynucleotidyl transferase rather than DNA polymerase. Their use without validation using a reference standard makes comparisons difficult.
It is interesting that, using carefully controlled techniques on rapidly fixed tissue, the ISEL approach on sections has been used to demonstrate the occasional apoptotic cell on or near the tips of the villus 6-8 and yet others at positions 9 -11. These studies involved a wide range of doses and a range of sampling times for each of the 18 cytotoxic agents studied initially (see Ijiri and Potten, 1987a, b; Li et al., 1992) . S, stem cells; T, transit cells. dependent on the hierarchical status of the cells within the tissue. As already mentioned, this is clearly evident during the process of spermatogenesis, but it is also very clear that in the small intestine spontaneous, radiation-induced and some drug-induced apoptosis is associated with the stem cell compartment (Potten, 1977 (Potten, , 1992 Ijiri and Potten, 1987a; Li et al., 1992; Potten et al., 1992) (Figure 3 ). Transit cells are capable of undergoing apoptosis following exposure to other cytotoxic agents and so possess the programme for this mode of death. However, following exposure to radiation or certain cytotoxics and chemical mutagens they cannot be forced to activate this programme (Ijiri and Potten, 1987b; Potten, 1992) . Virtually nothing is known about the hierarchical dependence of apoptosis whether it be spontaneous (i.e. related to proliferation) or damage induced in most tissues of the body or in tumours.
In the small intestine, however, we believe that the ability to induce apoptosis by a particular agent is related to the cellular heirarchy or lineage present; in other situations it may be related to age, differentiation status, etc. The senescent cell death outlined in the previous section is perhaps an interesting example here. In the intestine, some spontaneous apoptosis, which we believe is part of the stem cell homeostatic process, and some damage-induced apoptosis seems to have some specificity for the cells earliest in the lineage, but apoptosis also seems to be initiated in senescent sections from four mice) compared with the hypothelial distribution of actual stem cells and clonogenic (potential) stem cells (see Potten and Loeffler, 1990 excise the tissue at a later time. Thus, cells are deprived of oxygen and nutrients for a variable length of time. Good fixation is crucial for apoptosis in tissue sections. In our experience, DNA synthesis tends to be fairly robust, whereas mitosis and cell cycle progression may be much more sensitive. Cells in mitosis may start to die once the vascular supply has been disrupted and show characteristics of apoptosis. Entry into mitosis and into S-phase may be blocked, and if oxygen and nutrients are restricted for more than a brief critical time cells may die from any point in the cell cycle. Thus, although certain proliferative parameters (notably mitotic index) may decrease with the passage of time from the occlusion of blood vessels, the proportion of apoptotic or dying cells may actually increase. Again, these processes have not been extensively studied.
Conclusions
I certainly do not wish to be negative and suggest that apoptotic indices should not be measured, but I do suggest that considerable caution be exerted in the interpretation of the data obtained, particularly when comparing one sample with another and data from one laboratory with another. Some of the points that I have outlined should be taken into consideration. Some are relatively easy to accommodate, e.g. defining scoring criteria and detection thresholds, controlling fixation, avoiding comparisons between disparate systems, etc. Others may be more difficult, e.g. determining the duration of apoptosis, ascertaining whether a hierarchical dependence exists, etc.
There are other considerations that probably fall outside the scope of this commentary. These include the semanticphilosophical arguments concerning the definition of cell death -at what point does cell death occur and how do we recognise it? There are also the related ambiguities on the definition of programming: the distinction between cell suicide and cell murder and the often interchangeable use of the broader term programmed cell death and the specific term apoptosis, which can lead to confusion rather than clarity. These points inevitably also include the consideration of metabolic, morphological and functional or physiological death. In this article, I have concentrated on the morphological aspects. A particular physiological aspect is the loss of the reproductive potential of a cell. This definition of cell death is one commonly used by radiobiologists when clonal regeneration assays are used. There is a relatively clear distinction between, on the one hand, a previously reproductively active cell becoming completely sterile (incapable of any more cell divisions) and, on the other hand, a cell which can satisfy the clonogenic criterion of forming a clone containing a certain number of cells. However, in between are many categories of 'doomed' cells, cells with slowed growth, cells with limited division capacity and cells that prematurely differentiate. Furthermore, it is unclear whether a completely sterilised cell necessarily undergoes any morphological changes that would enable one to recognise it as apoptotic or necrotic. It is for these sorts of reasons that the apoptotic yield rarely relates to the yield of reproductively sterilised cells, at least in the gut (Potten, 1977; Hendry and Potten, 1982) .
